COST-EFFECTIVENESS OF ARSENIC TRIOXIDE plus ALL-TRANS RETINOIC ACID COMPARED WITH ALL-TRANS RETINOIC ACID plus IDARUBICIN IN THE TREATMENT OF NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LYMPHOMA LEUKEMIA IN CANADA

被引：0
|
作者：
Lachaine, J. [1 ]
Mathurin, K. [1 ]
Barakat, S. [2 ]
机构：
[1] Univ Montreal, Montreal, PQ, Canada
[2] Lundbeck Canada, Montreal, PQ, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.486
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN91
引用
收藏
页码：A83 / A83
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness Of Arsenic Trioxide plus All-Trans Retinoic Acid Compared With All-Trans Retinoic Acid plus Idarubicin In The Treatment Of Newly Diagnosed Acute Promyelocytic Leukemia In Canada
    Lachaine, Jean
    Mathurin, Karine
    Barakat, Stephane
    BLOOD, 2013, 122 (21)
  • [2] All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis
    Ma, Yafang
    Liu, Lu
    Jin, Jie
    Lou, Yinjun
    PLOS ONE, 2016, 11 (07):
  • [3] Incidence of secondary neoplasms in patients with acute promyelocytic leukemia treated with all-trans retinoic acid plus chemotherapy or with all-trans retinoic acid plus arsenic trioxide
    Eghtedar, Alireza
    Rodriguez, Ildefonso
    Kantarjian, Hagop
    O'Brien, Susan
    Daver, Naval
    Garcia-Manero, Guillermo
    Ferrajoli, Alessandra
    Kadia, Tapan
    Pierce, Sherry
    Cortes, Jorge
    Ravandi, Farhad
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1342 - 1345
  • [4] Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid
    Autore, Francesco
    Chiusolo, Patrizia
    Sora, Federica
    Giammarco, Sabrina
    Laurenti, Luca
    Innocenti, Idanna
    Metafuni, Elisabetta
    Piccirillo, Nicola
    Pagano, Livio
    Bacigalupo, Andrea
    Leone, Giuseppe
    Sica, Simona
    LEUKEMIA & LYMPHOMA, 2019, 60 (05) : 1328 - 1330
  • [5] Arsenic trioxide and all-trans retinoic acid in the treatment of children with newly diagnosed acute promyelocytic leukemia
    Li, Shuang-Yue
    Lu, Ying
    Liu, Hsiao-Chuan
    Gang, Eun Ji
    Le, Jing
    Qian, Su-Ying
    Tang, Shan-Hao
    Si, Ting
    Pei, Ren-Zhi
    LEUKEMIA & LYMPHOMA, 2021, 62 (05) : 1267 - 1270
  • [6] Therapeutic effects of arsenic trioxide plus all-trans retinoic acid on acute promyelocytic leukemia
    Zhang, Lili
    Zhang, Yujing
    Li, Zhiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7536 - 7544
  • [7] Switching from all-trans retinoic acid to arsenic trioxide for newly diagnosed acute promyelocytic leukemia
    Imagawa, Jun
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 3013 - 3015
  • [8] Economic evaluation of arsenic trioxide compared to all-trans retinoic acid plus conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada
    Lachaine, Jean
    Mathurin, Karine
    Barakat, Stephane
    Couban, Stephen
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 95 (03) : 218 - 229
  • [9] Use of all-trans retinoic acid plus arsenic trioxide as alternative to chemotherapy in untreated acute promyelocytic leukemia
    Estey, E.
    ANNALS OF HEMATOLOGY, 2006, 85 : 67 - 68
  • [10] Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia
    Estey, E
    Garcia-Manero, G
    Ferrajoli, A
    Faderl, S
    Verstovsek, S
    Jones, D
    Kantarjian, H
    BLOOD, 2006, 107 (09) : 3469 - 3473
12345